Resources

These social media tiles can be used by general practices to help communicate with their patients about the COVID-19 vaccination program.

This communique provides a summary of the advisory committee's meeting on 3 April 2023.

The Department of Health (the Department) provided updates on the COVID-19 vaccination rollout for people with disability and disability support workers.

The Department of Health (the Department) provided updates on the COVID-19 vaccination rollout for people with disability and disability support workers.

This form is to help vaccine providers report a potential cold chain breach under the COVID-19 vaccination program.

This collection contains regular updates for disability service providers about the COVID-19 vaccination rollout.

Have any questions about immunisation or vaccinations? We have compiled answers to the most frequently asked questions about childhood vaccinations

VCF Connect allows vaccination providers to self-manage vaccination service information.

To provide information for consumers on people eligible for a free influenza vaccine through the National Immunisation Program.

This poster provides information about the influenza vaccine for parents of young children and can be used in health care and community settings.

This fact sheet provides advice for vaccination providers on administering influenza vaccines in 2023.

This decision guide to COVID-19 vaccination is for women who are pregnant, breastfeeding or planning pregnancy.

These guidelines from the Australian Technical Advisory Group on Immunisation (ATAGI) provide advice on the management of a range of possible vaccine administration errors, including when a replacement (repeat) dose is recommended.

These spreadsheets provide immunisation coverage data by Statistical Areas Level 3 (SA3) for Queensland.

These spreadsheets provide immunisation coverage data by Statistical Areas Level 3 (SA3) for South Australia.

This collection contains program advice for providers administering vaccines through the National Immunisation Program (NIP).

This fact sheet for providers outlines the changes to human papillomavirus (HPV) vaccination under the National Immunisation Program (NIP) in 2023.

Evusheld® (tixagevimab and cilgavimab) by AstraZeneca Pty Ltd is the first medication for the pre-exposure prophylaxis of COVID-19 in Australia.

These spreadsheets provide 2022 childhood immunisation coverage data by Primary Health Network (PHN), for all children and Aboriginal and Torres Strait Islander children.

These spreadsheets provide immunisation coverage data by Statistical Areas Level 3 (SA3) for Western Australia.

These spreadsheets provide immunisation coverage data by Statistical Areas Level 3 (SA3) for Victoria.

These spreadsheets provide immunisation coverage data by Statistical Areas Level 3 (SA3) for Tasmania.

These spreadsheets provide immunisation coverage data by Statistical Areas Level 3 (SA3) for the Northern Territory.

These spreadsheets provide immunisation coverage data by Statistical Areas Level 3 (SA3) for New South Wales.

These spreadsheets provide immunisation coverage data by Statistical Areas Level 3 (SA3) for the Australian Capital Territory.